7Baggers
 published on: 2025-09-18 20:35:50  خودرو بانک Thu, 18 Sep 2025 17:09:07 GMT
 indaptus therapeutics expands cancer trial to canada  MSN Wed, 17 Sep 2025 03:11:26 GMT
 breakout move: is indaptus therapeutics inc stock a good pick for beginners  خودرو بانک Tue, 16 Sep 2025 06:30:54 GMT
 published on: 2025-09-15 13:17:15  newser.com Mon, 15 Sep 2025 18:17:15 GMT
 published on: 2025-09-14 00:54:54  newser.com Sun, 14 Sep 2025 05:54:54 GMT
 published on: 2025-09-12 18:49:19  Newser Fri, 12 Sep 2025 23:49:19 GMT
 published on: 2025-09-12 05:38:46  Newser Fri, 12 Sep 2025 10:38:46 GMT
 published on: 2025-09-12 00:32:46  Newser Fri, 12 Sep 2025 05:32:46 GMT
 published on: 2025-09-12 00:17:00  Newser Fri, 12 Sep 2025 05:17:00 GMT
 published on: 2025-09-11 03:52:47  Newser Thu, 11 Sep 2025 08:52:47 GMT
 published on: 2025-09-09 17:42:25  Newser Tue, 09 Sep 2025 22:42:25 GMT
 published on: 2025-09-09 02:04:21  Newser Tue, 09 Sep 2025 07:04:21 GMT
 published on: 2025-09-08 21:06:27  Newser Tue, 09 Sep 2025 02:06:27 GMT
 published on: 2025-09-08 20:08:05  Newser Tue, 09 Sep 2025 01:08:05 GMT
 published on: 2025-09-08 15:18:14  Newser Mon, 08 Sep 2025 20:18:14 GMT
 published on: 2025-09-08 15:05:50  Newser Mon, 08 Sep 2025 20:05:50 GMT
 published on: 2025-09-08 09:56:22  Newser Mon, 08 Sep 2025 14:56:22 GMT
 published on: 2025-09-08 13:27:01  beatles.ru Mon, 08 Sep 2025 10:27:42 GMT
 published on: 2025-09-05 13:40:19  Newser Fri, 05 Sep 2025 18:40:19 GMT
 indaptus reports partial response in cancer patient with decoy20 by investing.com  Investing.com Canada Fri, 05 Sep 2025 09:26:29 GMT
 Indaptus Therapeutics stock falls after mixed clinical trial updates  Investing.com Fri, 05 Sep 2025 07:00:00 GMT
 Indaptus Therapeutics Provides Clinical Update  The Manila Times Fri, 05 Sep 2025 07:00:00 GMT
 Indaptus Therapeutics Provides Clinical Update  Yahoo Finance Thu, 04 Sep 2025 07:00:00 GMT
 Indaptus Therapeutics Reports Mixed Results in Clinical Trial  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 Indaptus reports partial response in cancer patient with Decoy20  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 05:54:24  Newser Wed, 03 Sep 2025 10:54:24 GMT

Indaptus Therapeutics, Inc.
(NASDAQ:INDP) 

INDP stock logo

Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. It engages in developing a pre-clinical pipeline of therapeutic candidates intended to elicit anti-tumor and anti-viral responses, as well as cure diseases. The company's l...

CEO: Jeffrey A. Meckler  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends